BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33687171)

  • 21. [Endocervical adenocarcinomas classified by International Endocervical Adenocarcinoma Criteria and Classification: a clinicopathological and prognostic analysis of 286 cases].
    Lyu BJ; Shi HY; Shao Y; Liu Q; Lyu WG
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1014-1019. PubMed ID: 34496491
    [No Abstract]   [Full Text] [Related]  

  • 22. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.
    Park KJ
    Histopathology; 2020 Jan; 76(1):112-127. PubMed ID: 31846527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical Adenocarcinoma: A Comparison of the Reproducibility of the World Health Organization 2003 and 2014 Classifications.
    Sar A; Duan Q; Khalil M; DiFrancesco LM; Ewanowich C; Lytwyn A; Djordjevic B; Itani D; Lee S; Köbel M; Glaze S; Park E; Duggan MA
    J Low Genit Tract Dis; 2018 Apr; 22(2):132-138. PubMed ID: 29474242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application and clinical significance of Silva pattern system in invasive endocervical adenocarcinoma].
    Song GY; Wang W; Wang YP; Liu M; Wang YX; Liu Y; Liu CR
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jan; 54(1):13-18. PubMed ID: 30695900
    [No Abstract]   [Full Text] [Related]  

  • 27. Update on the ISGyP Endocervical Adenocarcinoma Project.
    Int J Gynecol Pathol; 2020 Jul; 39(4):1. PubMed ID: 32511214
    [No Abstract]   [Full Text] [Related]  

  • 28. [Correlation of micropapillary patten, cribriform pattern and retraction clefting of endocervical adenocarcinoma with the Silva classification system and prognosis].
    Li YM; He YY; Sun PL; Gao HW
    Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):596-601. PubMed ID: 35750638
    [No Abstract]   [Full Text] [Related]  

  • 29. The ISGyP Endocervical Adenocarcinoma Project.
    Oliva E
    Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S1-S3. PubMed ID: 33570860
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of human papillomavirus (HPV) prediction using the International Endocervical Adenocarcinoma Criteria and Classification system, compared to p16 immunohistochemistry and HPV RNA in-situ hybridization.
    Ren H; Pors J; Chow C; Ta M; Stolnicu S; Soslow R; Huntsman D; Hoang L
    J Pathol Transl Med; 2020 Nov; 54(6):480-488. PubMed ID: 32854489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern based classification of endocervical adenocarcinoma: a review.
    Park KJ; Roma AA
    Pathology; 2018 Feb; 50(2):134-140. PubMed ID: 29241973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
    Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symposium part 3: Should pathologists diagnose endocervical preneoplastic lesions "less than" adenocarcinoma in situ?: Point.
    Ioffe OB; Sagae S; Moritani S; Dahmoush L; Chen TT; Silverberg SG
    Int J Gynecol Pathol; 2003 Jan; 22(1):18-21. PubMed ID: 12496692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current FIGO Staging for Carcinoma of the Cervix Uteri and Treatment of Particular Stages.
    Sehnal B; Kmoníčková E; Sláma J; Tomancová V; Zikán M
    Klin Onkol; 2019; 32(3):224-231. PubMed ID: 31216857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dataset for the Reporting of Carcinoma of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
    Park KJ; Selinger CI; Alvarado-Cabrero I; Duggan MA; Kiyokawa T; Mills AM; Ordi J; Otis CN; Plante M; Stolnicu S; Talia KL; Wiredu EK; Lax SF; McCluggage WG
    Int J Gynecol Pathol; 2022 Nov; 41(Suppl 1):S64-S89. PubMed ID: 36305535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of the pattern-based classification in endocervical adenocarcinoma, usual and variants.
    Byun JM; Cho HJ; Park HY; Kim YN; Lee KB; Sung MS; Jeong CH; Jeong DH
    Int J Clin Oncol; 2019 Oct; 24(10):1264-1272. PubMed ID: 31140099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.
    Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Pike MC; Soslow RA
    Gynecol Oncol; 2018 Jul; 150(1):56-60. PubMed ID: 29859673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma.
    Fujiwara H; Yokota H; Monk B; Treilleux I; Devouassoux-Shisheboran M; Davis A; Kim JW; Mahner S; Stany M; Pignata S; Ray-Coquard I; Fujiwara K
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S96-101. PubMed ID: 25341589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists.
    Malpica A; Euscher ED; Hecht JL; Ali-Fehmi R; Quick CM; Singh N; Horn LC; Alvarado-Cabrero I; Matias-Guiu X; Hirschowitz L; Duggan M; Ordi J; Parkash V; Mikami Y; Ruhul Quddus M; Zaino R; Staebler A; Zaloudek C; McCluggage WG; Oliva E
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S9-S24. PubMed ID: 30550481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome.
    Roma AA; Mistretta TA; Diaz De Vivar A; Park KJ; Alvarado-Cabrero I; Rasty G; Chanona-Vilchis JG; Mikami Y; Hong SR; Teramoto N; Ali-Fehmi R; Barbuto D; Rutgers JK; Silva EG
    Gynecol Oncol; 2016 Apr; 141(1):36-42. PubMed ID: 27016227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.